Showing results (431-440 of 572) with videos related to

Sort By:
Pageof 58
Blood|July 15, 1993
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridizationH Kobayashi, R Espinosa, M J Thirman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulinScott D Rowley, Stuart L Goldberg, Andrew L Pecora, et al.
Frontiers in Neuroscience|November 12, 2015
Assessing intracortical myelin in the living human brain using myelinated cortical thicknessChristopher D Rowley, Pierre-Louis Bazin, Christine L Tardif, et al.
Cancer Research|May 1, 1992
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomasO I Olopade, R B Jenkins, D T Ransom, et al.
Blood|August 1, 1996
TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell linesD H Kim, R L Moldwin, C Vignon, et al.
Leukemia|August 2, 2001
Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clonesY Sato, H Kobayashi, Y Suto, et al.
Genes, Chromosomes & Cancer|September 18, 1997
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic studyT W McKeithan, G S Takimoto, H Ohno, et al.
Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.
Genetica|February 20, 2008
Comparative gene mapping in cattle, Indian muntjac, and Chinese muntjac by fluorescence in situ hybridizationAndrea E Murmann, Antoaneta Mincheva, Markus O Scheuermann, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2002
A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrinF H Gordon, M I Hamilton, S Donoghue, et al.
Pageof 58